Clinical Trial Update: SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical Trial Update reports phase 1/2 study of SPL026 (DMT Fumarate) in healthy subjects and patients with Major Depressive Disorder, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPL026

Snippet

Sponsor: Small Pharma Ltd | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED